Emergent Book Value Per Share from 2010 to 2025

EBS Stock

USD 7.27 0.06 0.83%

Emergent Biosolutions Book Value Per Share yearly trend continues to be comparatively stable with very little volatility. Book Value Per Share will likely drop to 10.41 in 2025. Book Value Per Share is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of Emergent Biosolutions according to its financial statements. View All Fundamentals

Book Value Per Share

First Reported

2010-12-31

Previous Quarter

11.41

Current Value

10.41

Quarterly Volatility

8.01094135

Credit Downgrade

Yuan Drop

Covid

Check Emergent Biosolutions financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Emergent Biosolutions' main balance sheet or income statement drivers, such as Depreciation And Amortization of 151.1 M, Interest Expense of 106.1 M or Total Revenue of 1.3 B, as well as many indicators such as Price To Sales Ratio of 0.13, Dividend Yield of 0.018 or PTB Ratio of 0.21. Emergent financial statements analysis is a perfect complement when working with Emergent Biosolutions Valuation or Volatility modules.

Check out the analysis of Emergent Biosolutions Correlation against competitors.

For more information on how to buy Emergent Stock please use our How to Invest in Emergent Biosolutions guide.

Latest Emergent Biosolutions' Book Value Per Share Growth Pattern

Below is the plot of the Book Value Per Share of Emergent Biosolutions over the last few years. It is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements. Emergent Biosolutions' Book Value Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Emergent Biosolutions' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 9.40 X

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Book Value Per Share

Timeline

Emergent Book Value Per Share Regression Statistics

	Arithmetic Mean	16.59
	Coefficient Of Variation	48.29
	Mean Deviation	6.18
	Median	14.84
	Standard Deviation	8.01
	Sample Variance	64.18
	Range	32.0105
	R-Value	0.43
	Mean Square Error	56.28
	R-Squared	0.18
	Significance	0.1
	Slope	0.72
	Total Sum of Squares	962.63

Emergent Book Value Per Share History

	2025	10.41
	2024	11.41
	2023	12.68
	2022	27.6
	2021	30.26
	2020	27.46
	2019	21.14

Other Fundumenentals of Emergent Biosolutions

Tangible Book Value Per Share

Emergent Biosolutions Book Value Per Share component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Good Will	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Current Deferred Revenue	Long Term Debt	Short Term Investments	Property Plant Equipment	Deferred Long Term Liab	Treasury Stock	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.93	0.62	0.42	0.54	0.63	0.67	0.9	0.64	0.43	0.71	0.7	0.7	0.88	0.79	0.73	0.77	-0.58	0.88	0.85	0.86	0.14	0.58	0.89	0.15	0.02
Total Stockholder Equity	0.93		0.37	0.52	0.35	0.52	0.45	0.74	0.54	0.23	0.49	0.48	0.74	0.79	0.61	0.61	0.63	-0.4	0.77	0.76	0.71	-0.05	0.41	0.81	0.37	0.11
Net Debt	0.62	0.37		-0.19	0.7	0.52	0.71	0.88	0.36	0.69	0.75	0.72	0.26	0.61	0.91	0.84	0.82	-0.81	0.73	0.68	0.81	0.46	0.51	0.74	-0.49	-0.55
Retained Earnings	0.42	0.52	-0.19		0.29	0.44	0.38	0.17	0.75	-0.12	0.38	0.34	0.59	0.35	0.06	-0.12	0.06	0.13	0.2	0.3	0.08	-0.16	0.08	0.41	0.65	0.48
Accounts Payable	0.54	0.35	0.7	0.29		0.71	0.88	0.72	0.79	0.43	0.83	0.86	0.6	0.56	0.81	0.64	0.67	-0.64	0.73	0.64	0.69	0.24	0.63	0.72	-0.04	-0.43
Net Receivables	0.63	0.52	0.52	0.44	0.71		0.89	0.59	0.7	0.01	0.85	0.87	0.68	0.77	0.67	0.39	0.52	-0.29	0.67	0.76	0.65	-0.28	0.23	0.58	0.3	0.03
Good Will	0.67	0.45	0.71	0.38	0.88	0.89		0.74	0.79	0.31	0.98	0.98	0.6	0.74	0.8	0.51	0.65	-0.49	0.73	0.76	0.73	0.08	0.45	0.7	0.03	-0.11
Total Liab	0.9	0.74	0.88	0.17	0.72	0.59	0.74		0.59	0.63	0.78	0.75	0.58	0.82	0.94	0.89	0.89	-0.77	0.89	0.86	0.89	0.35	0.64	0.95	-0.15	-0.36
Total Current Assets	0.64	0.54	0.36	0.75	0.79	0.7	0.79	0.59		0.33	0.76	0.79	0.67	0.55	0.53	0.38	0.47	-0.42	0.65	0.55	0.56	0.16	0.57	0.69	0.24	0.07
Short Term Debt	0.43	0.23	0.69	-0.12	0.43	0.01	0.31	0.63	0.33		0.38	0.39	-0.08	0.1	0.54	0.69	0.51	-0.85	0.52	0.16	0.58	0.91	0.65	0.59	-0.74	-0.44
Intangible Assets	0.71	0.49	0.75	0.38	0.83	0.85	0.98	0.78	0.76	0.38		0.97	0.55	0.75	0.82	0.53	0.68	-0.52	0.72	0.76	0.74	0.16	0.42	0.75	-0.02	-0.1
Common Stock	0.7	0.48	0.72	0.34	0.86	0.87	0.98	0.75	0.79	0.39	0.97		0.57	0.72	0.81	0.57	0.66	-0.58	0.8	0.71	0.8	0.15	0.55	0.71	-0.03	-0.08
Current Deferred Revenue	0.7	0.74	0.26	0.59	0.6	0.68	0.6	0.58	0.67	-0.08	0.55	0.57		0.77	0.57	0.43	0.52	-0.22	0.67	0.77	0.55	-0.3	0.4	0.67	0.62	0.04
Long Term Debt	0.88	0.79	0.61	0.35	0.56	0.77	0.74	0.82	0.55	0.1	0.75	0.72	0.77		0.78	0.6	0.75	-0.36	0.76	0.98	0.73	-0.18	0.37	0.77	0.33	0.0
Short Term Investments	0.79	0.61	0.91	0.06	0.81	0.67	0.8	0.94	0.53	0.54	0.82	0.81	0.57	0.78		0.87	0.87	-0.77	0.88	0.84	0.9	0.26	0.59	0.88	-0.16	-0.45
Property Plant Equipment	0.73	0.61	0.84	-0.12	0.64	0.39	0.51	0.89	0.38	0.69	0.53	0.57	0.43	0.6	0.87		0.88	-0.9	0.88	0.67	0.9	0.4	0.72	0.8	-0.31	-0.58
Deferred Long Term Liab	0.77	0.63	0.82	0.06	0.67	0.52	0.65	0.89	0.47	0.51	0.68	0.66	0.52	0.75	0.87	0.88		-0.77	0.82	0.8	0.85	0.25	0.56	0.81	-0.13	-0.43
Treasury Stock	-0.58	-0.4	-0.81	0.13	-0.64	-0.29	-0.49	-0.77	-0.42	-0.85	-0.52	-0.58	-0.22	-0.36	-0.77	-0.9	-0.77		-0.79	-0.42	-0.82	-0.65	-0.78	-0.7	0.53	0.5
Net Tangible Assets	0.88	0.77	0.73	0.2	0.73	0.67	0.73	0.89	0.65	0.52	0.72	0.8	0.67	0.76	0.88	0.88	0.82	-0.79		0.77	0.98	0.19	0.75	0.84	-0.02	-0.24
Long Term Debt Total	0.85	0.76	0.68	0.3	0.64	0.76	0.76	0.86	0.55	0.16	0.76	0.71	0.77	0.98	0.84	0.67	0.8	-0.42	0.77		0.74	-0.13	0.37	0.81	0.27	-0.16
Capital Surpluse	0.86	0.71	0.81	0.08	0.69	0.65	0.73	0.89	0.56	0.58	0.74	0.8	0.55	0.73	0.9	0.9	0.85	-0.82	0.98	0.74		0.25	0.69	0.81	-0.17	-0.29
Short Long Term Debt	0.14	-0.05	0.46	-0.16	0.24	-0.28	0.08	0.35	0.16	0.91	0.16	0.15	-0.3	-0.18	0.26	0.4	0.25	-0.65	0.19	-0.13	0.25		0.54	0.33	-0.77	-0.35
Cash And Equivalents	0.58	0.41	0.51	0.08	0.63	0.23	0.45	0.64	0.57	0.65	0.42	0.55	0.4	0.37	0.59	0.72	0.56	-0.78	0.75	0.37	0.69	0.54		0.61	-0.21	-0.26
Net Invested Capital	0.89	0.81	0.74	0.41	0.72	0.58	0.7	0.95	0.69	0.59	0.75	0.71	0.67	0.77	0.88	0.8	0.81	-0.7	0.84	0.81	0.81	0.33	0.61		0.02	-0.28
Net Working Capital	0.15	0.37	-0.49	0.65	-0.04	0.3	0.03	-0.15	0.24	-0.74	-0.02	-0.03	0.62	0.33	-0.16	-0.31	-0.13	0.53	-0.02	0.27	-0.17	-0.77	-0.21	0.02		0.48
Capital Stock	0.02	0.11	-0.55	0.48	-0.43	0.03	-0.11	-0.36	0.07	-0.44	-0.1	-0.08	0.04	0.0	-0.45	-0.58	-0.43	0.5	-0.24	-0.16	-0.29	-0.35	-0.26	-0.28	0.48

Click cells to compare fundamentals

About Emergent Biosolutions Financial Statements

Emergent Biosolutions shareholders use historical fundamental indicators, such as Book Value Per Share, to determine how well the company is positioned to perform in the future. Although Emergent Biosolutions investors may analyze each financial statement separately, they are all interrelated. The changes in Emergent Biosolutions' assets and liabilities, for example, are also reflected in the revenues and expenses on on Emergent Biosolutions' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Book Value Per Share	11.41	10.41
Tangible Book Value Per Share	1.45	1.38

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Emergent Stock Analysis

When running Emergent Biosolutions' price analysis, check to measure Emergent Biosolutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emergent Biosolutions is operating at the current time. Most of Emergent Biosolutions' value examination focuses on studying past and present price action to predict the probability of Emergent Biosolutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Emergent Biosolutions' price. Additionally, you may evaluate how the addition of Emergent Biosolutions to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC